We are live on ! Find out more
CORV

Correvio Pharma Corp. Ordinary Shares (Canada)
CORV

Delisted

CORV was delisted on the 26th of May, 2020.

30 hedge funds and large institutions have $62.8M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

21% more capital invested

Capital invested by funds: $51.7M → $62.8M (+$11M)

12% more call options, than puts

Call options by funds: $210K | Put options by funds: $188K

11% more funds holding

Funds holding: 2730 (+3)

54% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 13

Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.8%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
6
Reduced
13
Closed
2
Calls
$210K
Puts
$188K
Net Calls
+$22K
Net Calls Change
+$291K
Name Holding Trade Value Shares
Change
Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$6K -$51.1K -6,064 -90%
PCM
27
Prelude Capital Management
New York
$6K +$5.05K +600 New
CLOS
28
Compagnie Lombard Odier SCmA
Switzerland
$1K
Creative Planning
29
Creative Planning
Kansas
$1K
Credit Agricole
30
Credit Agricole
France
-$250K -27,971 Closed
Bank of America
31
Bank of America
North Carolina
-$101K -11,966 -100%
Invesco
32
Invesco
Georgia
-$103K -11,518 Closed

CORV Hedge Fund Activity: Q4 2014 in Review

30 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q4 2014, worth a combined $62.8M — up 21% from $51.7M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CORV positions and 2 closed out — a net gain of 4 holders — while 6 added to existing stakes and 13 trimmed.

The largest buyer was Westfield Capital Management, adding an estimated $6.65M. The largest seller was Adage Capital Partners, cutting an estimated $2.95M.

  • 30 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q4 2014, up from 27 in Q3 2014.
  • Funds reported $62.8M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q4 2014, up 21% quarter-over-quarter.
  • 6 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q4 2014 and 2 closed out, a net change of +4 holders.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q4 2014 was Westfield Capital Management, an estimated $6.65M added.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q4 2014 was Adage Capital Partners, an estimated $2.95M sold.

Based on aggregated 13F filings for Q4 2014.